Retrieve available abstracts of 33 articles: HTML format
Single Articles
September 2025
TAQI K, Jonsson EL, Assadzad GE, Stockley C, et al Superparamagnetic Iron Oxide Tracer: A Magnetic Match to Gold Standard in
Melanoma Sentinel Lymph Node Biopsy-A Systematic Review and Meta-Analysis.
J Surg Oncol. 2025 Sep 10. doi: 10.1002/jso.70086. PubMedAbstract available
August 2025
KING A, Brandts-Longtin O, Somayaji C, McDonald JT, et al Impact of Social Determinants on Melanoma Outcomes in Canada: A Single-Centre
Retrospective Study.
J Surg Oncol. 2025 Aug 28. doi: 10.1002/jso.70069. PubMedAbstract available
July 2025
YANG Y, Fang H, Cai Z, Xu Q, et al Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Melanoma: A
Systematic Review and Meta-Analysis.
J Surg Oncol. 2025 Jul 11. doi: 10.1002/jso.70039. PubMedAbstract available
LAL T, Dong W, Koroukian SM, Chakraborty NN, et al Socioeconomic Influences on Melanoma Incidence Patterns by Stage in the US.
J Surg Oncol. 2025 Jul 10. doi: 10.1002/jso.70036. PubMedAbstract available
WEITEMEYER MB, Helvind NM, Klausen S, Clasen-Linde E, et al Validation of a Clinicopathologic and Gene Expression Model for Predicting
Sentinel Node Metastasis in Melanoma: A Multicenter Danish Cohort Study.
J Surg Oncol. 2025 Jul 7. doi: 10.1002/jso.70035. PubMedAbstract available
February 2025
LIU W, Yang Y Comment on "Lymph Node Dissection for Melanoma: Contemporary Trends in
Postoperative Outcomes and Patient Selection With Reduced Case Volumes in the
Post-MSLT2 Era".
J Surg Oncol. 2025 Feb 12. doi: 10.1002/jso.28118. PubMed
January 2025
FAROOQ MS, Vargas GM, Shafique N, Guo J, et al Lymph Node Dissection for Melanoma: Contemporary Trends in Postoperative Outcomes
and Patient Selection With Reduced Case Volumes in the Post-MSLT2 Era.
J Surg Oncol. 2025 Jan 8. doi: 10.1002/jso.28075. PubMedAbstract available
FANNING JE, Chung DKV, Reynolds HM, Jayathungage Don TD, et al Collateralization of the upper extremity lymphatic system after axillary lymph
node dissection.
J Surg Oncol. 2025;131:47-53. PubMedAbstract available
December 2024
DE LA CRUZ KU G, Guart JA, Farzan JJ, Desai A, et al Real World Data in Stage III Melanoma in Latino Low Middle Income Country:
Prognostic Factors and Outcomes.
J Surg Oncol. 2024 Dec 29. doi: 10.1002/jso.28047. PubMedAbstract available
November 2024
LOURDAULT K, Cowman AW, Hanes D, Scholer AJ, et al Are Nomograms Useful for Predicting Sentinel Lymph Node Status in Melanoma
Patients?
J Surg Oncol. 2024 Nov 17. doi: 10.1002/jso.27976. PubMedAbstract available
October 2024
YEE EJ, Thielen ON, Truong R, Gilbert D, et al Metastatic Melanoma to the Small Bowel and Colon: A Systematic Review of the
Global Experience and Institutional Cohort Analysis Detailing a Rare Clinical
Entity.
J Surg Oncol. 2024 Oct 28. doi: 10.1002/jso.27958. PubMedAbstract available
DRUSKOVICH C, Kelley J, Aubrey J, Palladino L, et al A Review of Melanoma Subtypes: Genetic and Treatment Considerations.
J Surg Oncol. 2024 Oct 16. doi: 10.1002/jso.27953. PubMedAbstract available
DHEER A, Tortorello GN, Shafique N, Farooq MS, et al Sequencing of Immunotherapy and Outcomes in Operable Clinical Stage III Melanoma:
A National Cohort Study.
J Surg Oncol. 2024 Oct 3. doi: 10.1002/jso.27933. PubMedAbstract available
September 2024
LI J, Cheng W Letter Regarding "Factors Associated With Skeletal-Related Events in Patients
With Bone Metastatic Melanoma: A Retrospective Study of 481 Patients".
J Surg Oncol. 2024 Sep 30. doi: 10.1002/jso.27915. PubMed
August 2024
FANNING JE, Singhal D, Reynolds HM, Don TDJ, et al Patterns of forearm lymphatic drainage to the epitrochlear lymph nodes in 1400
cutaneous melanoma patients.
J Surg Oncol. 2024 Aug 13. doi: 10.1002/jso.27811. PubMedAbstract available
SANTOS RLD, Martins MR, Tavares VL, Neto JPD, et al Analysis of the expression of cytokines and chemokines, platelet-leukocyte
aggregates, sCD40L and sCD62P in cutaneous melanoma.
J Surg Oncol. 2024 Aug 11. doi: 10.1002/jso.27748. PubMedAbstract available
June 2024
SHIMIZU MR, de Groot TM, Twining PK, Kobes T, et al Factors associated with skeletal-related events in patients with bone metastatic
melanoma: A retrospective study of 481 patients.
J Surg Oncol. 2024 Jun 17. doi: 10.1002/jso.27731. PubMedAbstract available
May 2024
GREENE AC, Matzelle-Zywicki M, Ziegler O, El-Mallah JC, et al Characteristics and variations in young adults with cutaneous melanoma: A
national cancer database analysis.
J Surg Oncol. 2024 May 19. doi: 10.1002/jso.27685. PubMedAbstract available
PARKER LM, Beekman KE, DePalo DK, Elleson KM, et al Evaluating the role of level 3 axillary lymph node dissection in metastatic
melanoma: Can we predict involvement?
J Surg Oncol. 2024 May 8. doi: 10.1002/jso.27664. PubMedAbstract available
March 2024
EMILE SH, Horesh N, Garoufalia Z, Gefen R, et al A national database analysis of the evolution of outcomes of surgery for anal
melanoma.
J Surg Oncol. 2024 Mar 27. doi: 10.1002/jso.27631. PubMedAbstract available
STEADMAN JA, Glasgow AE, Neequaye NN, Habermann EB, et al Distinct presentation of melanoma in Black patients may inform strategies to
improve outcomes.
J Surg Oncol. 2024 Mar 4. doi: 10.1002/jso.27608. PubMedAbstract available
KADHUM M, Mayr L, Pope-Jones S, Cubitt J, et al Sentinel lymph node biopsy for melanoma in the older population: A prospective
analysis of outcomes.
J Surg Oncol. 2024 Mar 4. doi: 10.1002/jso.27617. PubMedAbstract available
November 2023
MALEKZADEH P, Brady MS Adjuvant therapy for stage IIB + IIC melanoma.
J Surg Oncol. 2023 Nov 30. doi: 10.1002/jso.27534. PubMed
KAKISH H, Lal T, Thuener JE, Bordeaux JS, et al Is sentinel lymph node biopsy needed for lentigo maligna melanoma?
J Surg Oncol. 2023 Nov 29. doi: 10.1002/jso.27543. PubMedAbstract available
GOYAL A, Fei-Zhang DJ, Pawlik TM, Bentrem DJ, et al Associations of social vulnerability with truncal and extremity melanomas in the
United States.
J Surg Oncol. 2023 Nov 27. doi: 10.1002/jso.27532. PubMedAbstract available
KAKISH H, Drigotas C, Ahmed FA, Elshami M, et al The effect of surgical timing in nonmetastatic melanoma.
J Surg Oncol. 2023 Nov 20. doi: 10.1002/jso.27507. PubMedAbstract available
ASAI Y, Yanagawa N, Osakabe M, Yamada N, et al The clinicopathological impact of tumor-associated macrophages in patients with
cutaneous malignant melanoma.
J Surg Oncol. 2023 Nov 2. doi: 10.1002/jso.27487. PubMedAbstract available
September 2023
LIN X, Sun W, Ren M, Xu Y, et al Prediction of nonsentinel lymph node metastasis in acral melanoma with positive
sentinel lymph nodes.
J Surg Oncol. 2023 Sep 10. doi: 10.1002/jso.27438. PubMedAbstract available
July 2023
FASTNER S, Hieken TJ, McWilliams RR, Hyngstrom J, et al Anorectal melanoma.
J Surg Oncol. 2023 Jul 3. doi: 10.1002/jso.27381. PubMedAbstract available
April 2023
ASARE EA, Fisher SB, Chiang YJ, Haydu LE, et al Melanoma metastatic to the adrenal gland: An update on the role of adrenalectomy
in multidisciplinary management.
J Surg Oncol. 2023 Apr 3. doi: 10.1002/jso.27267. PubMedAbstract available
March 2023
HOLTKAMP LHJ, Lo SN, Thompson JF, Spillane AJ, et al Adjuvant radiotherapy after salvage surgery for melanoma recurrence in a node
field following a previous lymph node dissection.
J Surg Oncol. 2023 Mar 27. doi: 10.1002/jso.27245. PubMedAbstract available
SANTAMARIA-BARRIA JA, Matsuba C, Khader A, Scholar AJ, et al Age-related next-generation sequencing mutational analysis in 1196 melanomas.
J Surg Oncol. 2023 Mar 20. doi: 10.1002/jso.27239. PubMedAbstract available
HOSEIN S, Drebin HM, Kurtansky NR, Olofsson Bagge R, et al Are the MIA and MSKCC nomograms useful in selecting patients with melanoma for
sentinel lymph node biopsy?
J Surg Oncol. 2023 Mar 11. doi: 10.1002/jso.27231. PubMedAbstract available